UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

British journal of cancer, 2011-12, Vol.105 (12), p.1920-1926

2011

Volltextzugriff (PDF)

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Annals of oncology, 2016-08, Vol.27 (8), p.1612-1619

2016

Volltextzugriff (PDF)

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Annals of oncology, 2018-08, Vol.29 (8), p.1701-1709

2018

Volltextzugriff (PDF)

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 1989-11, Vol.7 (11), p.1602-1613

1989

Volltextzugriff (PDF)

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1615-1622

1995

Volltextzugriff (PDF)

EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma

American journal of clinical oncology, 1993-08, Vol.16 (4), p.342-345

1993

Volltextzugriff (PDF)

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer

The Annals of thoracic surgery, 1989-05, Vol.47 (5), p.669-677

1989

Volltextzugriff (PDF)

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (PZ586)

Lung cancer, 1999-09, Vol.25 (3), p.199-206

1999

Volltextzugriff (PDF)

Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: An eastern cooperative oncology group study (PB586)

American journal of clinical oncology, 2000-08, Vol.23 (4), p.371-375

2000

Volltextzugriff (PDF)

Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study

JNCI : Journal of the National Cancer Institute, 1992-07, Vol.84 (14), p.1077-1084

1992

Volltextzugriff (PDF)

Simultaneous Cisplatin Fluorouracil Infusion and Radiation Followed by Surgical Resection in Regionally Localized Stage III, Non–Small Cell Lung Cancer

The Annals of thoracic surgery, 1987-01, Vol.43 (1), p.87-91

1987

Volltextzugriff (PDF)

Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18047-e18047

2011

Volltextzugriff (PDF)

Retreatment of Recurrent Invasive Thymoma with Platinum, Doxorubicin, and Cyclophosphamide

Chest, 1996-10, Vol.110 (4), p.1115-1117

1996

Volltextzugriff (PDF)

Simultaneous inhibition of EGFR and c-Met pathways in a panel of NSCLC cell lines

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22223-22223

2008

Volltextzugriff (PDF)

Assessment and targeting of growth factor-binding heparan sulfate 6- O -sulfated motifs on lung cancer cell lines using human single chain antibody variable fragments

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14015-14015

2008

Volltextzugriff (PDF)

Hormone receptor studies in axillary metastases from occult breast cancers

Cancer, 1987-03, Vol.59 (6), p.1170-1172

1987

Volltextzugriff (PDF)

Prognostic importance of subdividing clinically staged IIIa and IIIb patients with non-small-cell lung cancer

Journal of clinical oncology, 1991-02, Vol.9 (2), p.357-359

1991

Volltextzugriff (PDF)

Increased Bcl-2 expression is associated with Bax promoter hypermethylation in neuroendocrine carcinoma (NEC) of the lung

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21136-e21136

2011

Volltextzugriff (PDF)

Histologic subtyping and tumor stromal responses in advanced-stage lung adenocarcinoma and their relationship to survival

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21135-e21135

2011

Volltextzugriff (PDF)

Phase II randomized, open-label study of cetuximab (Cet) and bevacizumab (Bev) in combination with paclitaxel (P) and carboplatin (C) in patients with stageIII/IV non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8046-8046

2009

Volltextzugriff (PDF)

Expression of sonic hedgehog and its receptor patched in non-small cell lung cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7620-7620

2010

Volltextzugriff (PDF)

Evaluation of pre- and post-treatment related to outcome in advanced non-small cell lung cancer (NSCLC) patients treated with split course concurrent chemoradiotherapy (CRT) followed by resection: A single-institution series of 49 patients

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e17510-e17510

2010

Volltextzugriff (PDF)

Mcl-1 and bcl-2 expression in neuroendocrine carcinoma (NEC) and potential for new therapeutic target

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e21039-e21039

2010

Volltextzugriff (PDF)

Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: Long-term results and patterns of failure

International journal of radiation oncology, biology, physics, 1990-08, Vol.19 (2), p.287-292

1990

Volltextzugriff (PDF)

Association of epithelial mesenchymal transition (EMT) markers and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7550-7550

2010

Volltextzugriff (PDF)

1 – 25 von 598

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(526)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study

EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (PZ586)

Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: An eastern cooperative oncology group study (PB586)

Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized Study

Simultaneous Cisplatin Fluorouracil Infusion and Radiation Followed by Surgical Resection in Regionally Localized Stage III, Non–Small Cell Lung Cancer

Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

Retreatment of Recurrent Invasive Thymoma with Platinum, Doxorubicin, and Cyclophosphamide

Simultaneous inhibition of EGFR and c-Met pathways in a panel of NSCLC cell lines

Assessment and targeting of growth factor-binding heparan sulfate 6- O -sulfated motifs on lung cancer cell lines using human single chain antibody variable fragments

Hormone receptor studies in axillary metastases from occult breast cancers

Prognostic importance of subdividing clinically staged IIIa and IIIb patients with non-small-cell lung cancer

Increased Bcl-2 expression is associated with Bax promoter hypermethylation in neuroendocrine carcinoma (NEC) of the lung

Histologic subtyping and tumor stromal responses in advanced-stage lung adenocarcinoma and their relationship to survival

Phase II randomized, open-label study of cetuximab (Cet) and bevacizumab (Bev) in combination with paclitaxel (P) and carboplatin (C) in patients with stageIII/IV non-small cell lung cancer (NSCLC)

Expression of sonic hedgehog and its receptor patched in non-small cell lung cancer

Evaluation of pre- and post-treatment related to outcome in advanced non-small cell lung cancer (NSCLC) patients treated with split course concurrent chemoradiotherapy (CRT) followed by resection: A single-institution series of 49 patients

Mcl-1 and bcl-2 expression in neuroendocrine carcinoma (NEC) and potential for new therapeutic target

Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: Long-term results and patterns of failure

Association of epithelial mesenchymal transition (EMT) markers and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib

Suchergebnisse filtern